Morgan Stanley Pa Vmed Inc. Transaction History

Morgan Stanley

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	SELL	$0.22 - $0.5 $5,287 - $12,018	-24,036 Reduced 29.94%	56,239 $16,000
Q2 2023 Aug 14, 2023	SELL	$0.35 - $0.56 $7,039 - $11,263	-20,114 Reduced 20.04%	80,275 $32,000
Q1 2023 May 15, 2023	SELL	$0.36 - $0.63 $11,877 - $20,784	-32,992 Reduced 24.74%	100,389 $37,000
Q4 2022 Feb 14, 2023	SELL	$0.41 - $18.6 $18,499 - $839,232	-45,120 Reduced 25.28%	133,381 $64,000
Q3 2022 Nov 14, 2022	SELL	$0.57 - $34.65 $37,871 - $2.3 Million	-66,442 Reduced 27.13%	178,501 $154,000
Q2 2022 Oct 27, 2022	SELL	$0.85 - $1.41 $175,517 - $291,152	-206,491 Reduced 45.74%	244,943 $229,000
Q2 2022 Aug 15, 2022	SELL	$0.85 - $1.41 $175,517 - $291,152	-206,491 Reduced 45.74%	244,943 $229,000
Q1 2022 Oct 27, 2022	BUY	$1.16 - $2.5 $239,529 - $516,227	206,491 Added 84.3%	451,434 $596,000
Q1 2022 May 13, 2022	SELL	$1.16 - $2.5 $775,019 - $1.67 Million	-668,120 Reduced 59.68%	451,434 $596,000
Q4 2021 Feb 14, 2022	SELL	$2.46 - $8.74 $48,516 - $172,370	-19,722 Reduced 1.73%	1,119,554 $2.76 Million
Q3 2021 Nov 15, 2021	BUY	$5.1 - $9.39 $5.81 Million - $10.7 Million	1,139,276 New	1,139,276 $9.73 Million

2.24M

Ticker PAVM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 90,999,104
Market Cap $52.8M
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.